Capital International’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
Capital International's ASND Position: Q3 2026 in Review
Capital International reduced its Ascendis Pharma (ASND) stake by 26% in Q3 2026, selling an estimated $1.09M and leaving 12,098 shares worth $2.76M. The position accounts for 0.09% of the portfolio, ranked #135.
Capital International first reported a position in ASND in Q4 2024 and has held it in 8 quarters since. The position peaked at $4.37M in Q2 2026. 347 funds tracked by Wall St. Rank hold ASND as of Q3 2026.
- Capital International held 12,098 shares of Ascendis Pharma worth $2.76M as of Q3 2026.
- Capital International sold 4,296 Ascendis Pharma shares in Q3 2026, an estimated $1.09M.
- Ascendis Pharma made up 0.09% of Capital International's portfolio in Q3 2026, its #135 holding.
- Capital International first reported a position in Ascendis Pharma in Q4 2024 and has held it in 8 quarters since.
- Capital International's Ascendis Pharma position peaked at $4.37M in Q2 2026.
- 347 funds tracked by Wall St. Rank held Ascendis Pharma as of Q3 2026.
Based on Capital International's 13F filing for Q3 2026, filed 12 Nov 2026.